Cryo-Cell International, Inc. (CCEL) Research

Cryo-Cell International, Inc. specializes in the cryogenic preservation and processing of cells, primarily focusing on collecting and storing umbilical cord blood stem cells for personal family use. The company also offers a cord tissue banking service, securing a section of the umbilical cord itself. This tissue is a valuable source of mesenchymal stem cells, which are utilized in regenerative medicine to address a range of conditions, including various heart and kidney diseases, Amyotrophic Lateral Sclerosis (ALS), wound healing, and autoimmune disorders. Furthermore, Cryo-Cell manufactures and distributes its proprietary PrepaCyte CB processing system, specifically designed for umbilical cord blood stem cells. With a substantial global presence, the company safeguards approximately 500,000 units of cord blood and cord tissue stem cells. Their marketing efforts include direct outreach to expectant parents, alongside disseminating information through a network of healthcare professionals such as obstetricians, pediatricians, childbirth educators, and certified nurse-midwives. Established in 1989, Cryo-Cell International, Inc. is headquartered in Oldsmar, Florida.

Open Cryo-Cell International, Inc. (CCEL) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.